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shown to be naturally infected with 
Zaire Ebolavirus and Marburg virus. 
Thus, R. amplexicaudatus bats are a 
possible natural reservoir of REBOV. 
However, only 16 specimens of R. 
amplexicaudatus bats were available 
in this study, and it will be necessary 
to investigate more specimens of this 
species to detect the REBOV genome 
or antigens to conclude the bat is a 
natural reservoir for REBOV.
We have shown that R. 
amplexicaudatus bats are putatively 
infected with REBOV or closely related 
viruses in the Philippines. Antibody-
positive bats were captured at the sites 
near the study areas, where REBOV 
infections in cynomolgus monkeys 
and swine have been identifi ed. Thus, 
bats are a possible natural reservoir 
of REBOV. Further analysis to 
demonstrate the REBOV genome in 
bats is necessary to conclude that the 
bat is a reservoir of REBOV.
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Acute Hepatitis C 
Outbreak among 
HIV-infected Men, 
Madrid, Spain
To the Editor: In the past 
decade, hepatitis C virus (HCV) has 
emerged as a sexually transmitted 
infection (STI) among HIV-infected 
men who have sex with men (MSM). 
The epidemic was originally reported 
in several northern European 
countries (England, France, 
Germany, and the Netherlands) (1) 
and soon after in Australia (2) and 
the United States (3). Acute HCV 
acquisition was associated with 
group sex, unprotected receptive 
anal intercourse, and according to 
some studies, concomitant STI (4). 
Molecular phylogenetic studies 
suggested evidence of an international 
transmission network of MSM within 
northern Europe (1). However, 
expansion of the HCV epidemic 
among MSM to Spain (5) or to other 
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countries of the Mediterranean area 
had not previously been reported.
We report 4 cases of acute HCV in 
HIV-infected MSM in Madrid, Spain, 
2010. These patients were monitored 
at a university-affi liated hospital in 
downtown Madrid, which provides 
health care to a large MSM community 
in the Chueca District. Diagnosis of 
acute HCV was made by using the 
following criteria of the European 
AIDS Treatment Network (6): 1) 
positive HCV RNA; 2) an acute rise in 
alanine aminotransferase level >5× the 
normal upper limit, with documented 
normal alanine aminotransferase 
level within 12 months; and 3) 
negative results for anti–hepatitis A 
virus immunoglobulin M and anti–
hepatitis B core immunoglobulin M 
(when other causes of acute hepatitis 
were excluded). An HCV RNA 
load fl uctuation of >1 log10 IU/mL, 
if present, was considered further 
evidence of acute HCV infection (7).
All 4 patients were MSM 
with well-controlled HIV infection 
who were receiving antiretroviral 
treatment. During routine medical 
screening, they were found to have 
newly elevated liver transaminase 
levels, and further assessment 
confi rmed the diagnosis of acute HCV 
infection (Table). Three patients had 
received a diagnosis of STI in the 
previous 6 months, but only 1 patient 
acknowledged having unprotected anal 
intercourse. In addition, only 1 patient 
acknowledged using any recreational 
drugs (amyl nitrate); all denied using 
injection drugs (Table). All patients 
had lived in Madrid for at least 5 years 
before receiving a diagnosis of acute 
HCV. No patients reported having sex 
during international travel, using sex 
toys, or fi sting.
The patients described here lived 
in the Chueca District of Madrid, the 
largest MSM community in Spain, 
which is frequented by MSM traveling 
from smaller cities in Spain and other 
countries. Two of the 3 patients were 
infected with HCV genotype 4, which 
is unusual in patients from outside 
the Middle East and Africa (8) yet 
unexpectedly common in northern 
European HCV outbreaks (1), which 
suggests that the patients reported 
here may have been part of the social 
network originating in the north. 
Further sequencing of these isolates 
is under way to address this issue. 
The third patient with an identifi able 
HCV genotype was infected with 
HCV genotype 1, the most common 
genotype among HIV-infected MSM 
in northern Europe (1). These fi ndings 
suggest that a larger, undetected 
outbreak of HCV infection is taking 
place in Madrid. 
Although the patients reported 
here described fewer risks for sexual 
acquisition of HCV than patients from 
northern Europe or the United States, 
3 had recent STI, which suggests 
that they underreported their risks 
for HCV acquisition. This temporal 
association between STI and acute 
HCV in these patients suggests that 
the pattern of emergence of sexually 
transmitted HCV among MSM in 
Spain might be similar to that seen in 
northern Europe, following regional 
epidemics of syphilis (starting in 2000) 
(9,10). We therefore encourage HIV 
specialists and general practitioners, 
when investigating an STI, to perform 
HCV testing on MSM as well as on 
persons with newly elevated liver 
aminotransferase levels.
Ana Montoya-Ferrer, 
Daniel Seth Fierer,
Beatriz Alvarez-Alvarez, 
Miguel de Gorgolas, and 
Manuel L. Fernandez-Guerrero
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Table. Description of 4 HIV-infected men with HCV infection, Madrid, Spain, 2010* 
Characteristic? Patient 1 Patient 2 Patient 3? Patient 4
Age, y? 31 41 39? 39
Country of origin? Italy Ecuador Spain? Spain
Date of HIV diagnosis? 2006 Jun 2000 Jul 1998? 2001
Year ART initiated? 2008 2000 2006? 2006
Prior negative HCV test? 2006 None† None† 2008
Date AHC diagnosed? May 2010 May 2010 May 2010? May 2010
CD4 count, cells/?L? 562 327 787? 750
HIV viral load? Undetectable Undetectable Undetectable? Undetectable
Symptoms at diagnosis? No Mild asthenia only No? No
ALT/AST levels at AHC diagnosis, U/L? 564/331 304/216 222/114? 261/125
HCV genotype? 4 4 1a? Indeterminate
HCV RNA load, IU/mL (log10 IU/mL)? 950,556 (5.98) 629,875 (5.80) 11,827 (4.07)? 2,254,258 (6.35)
HCV RNA load fluctuation within 3 mo, log10 IU/mL 4.32 <1.00 1.33? <1.00
Unprotected anal intercourse? No No No? Serosorting‡
STI in previous 6 mo? Proctitis Syphilis No? Proctitis
Group sex (>2 persons)? Yes No No? No
Drug use? Amyl nitrate only No No? No
*HCV, hepatitis C virus; ART: antiretroviral therapy; AHC, acute hepatitis C infection; ALT, alanine aminotransferase; AST, aspartate aminotransferase; 
STI, sexually transmitted infection.  
†Both patients had normal transaminase levels in the 4 y before AHC diagnosis. 
‡Unprotected sex between seroconcordant partners (HIV positive). 
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Saffold Virus 
Infection in 
Children, Malaysia, 
2009
To the Editor: Since 2007, 
a new cardiovirus, named Saffold 
virus (SAFV), has been isolated from 
human specimens in the United States, 
Canada, the Netherlands, and People’s 
Republic of China (1–4). Concurrent 
investigations also showed that 
SAFV could be detected in feces and 
respiratory secretions of children in 
other countries, and genetic analysis 
showed the circulation of different 
genetic lineages of SAFVs in various 
parts of the world. This new virus 
belongs to the genus Cardiovirus, in 
the family Picornaviridae (5). Here 
we report isolation of a new SAFV in 
Malaysia, designated SAFV-Penang 
to refl ect the locality of isolation in 
Malaysia.
A 5-year-old girl was brought 
to a government outpatient clinic on 
November 18, 2009, with reported 
fever and sore throat for 3 days. The 
fever was described as of high grade 
with occasional episodes of rigor, 
accompanied by profuse sweating 
and myalgia, lethargy, and loss of 
appetite. The child had nasal blockage, 
mild runny nose, and dry cough. She 
vomited twice on day 3 of illness and 
had abdominal pain but no diarrhea. 
There was no history of similar illness 
affecting other family members, who 
lived in a semirural area within the state 
of Penang, Malaysia. Acute pharyngitis/
acute infl uenza-like illness was 
provisionally diagnosed, and a throat 
swab specimen was collected in virus 
transport medium for virus isolation by 
using established procedures (6).
The throat swab sample was 
treated with antimicrobial drugs for 
1 h before the cells were added to 
MDCK, Vero, and Hep-2 cells. On 
the fi fth day postinoculation (dpi), a 
lytic form of cytopathic effect (CPE), 
similar to the type of CPE from 
enterovirus infection, was noted in 
Hep-2 but not in Vero or MDCK cells. 
The progress of CPE was slow, and 
full CPE was achieved on 9 dpi. On 
8 dpi, a 0.5-mL aliquot containing 
infected Hep-2 cell suspension was 
removed and processed for indirect 
immunofl uorescence assay by 
using a panel of commercial typing 
monoclonal antibodies for human 
enteroviruses. The infected Hep-
2 cells reacted strongly with broad 
reactive pan-enterovirus monoclonal 
antibodies (catalog no. 3360, 
Chemicon Inc., Temecula, CA, USA) 
but failed to react with any type-
specifi c monoclonal antibodies (data 
not shown).
After 3 passages in Hep-2 cells, 
culture supernatant was subsequently 
passed into Vero cells. After an 
additional 3 passages, the virus was 
fully adapted to grow in Vero cells and 
was able to induce visible CPE 1 dpi 
and full CPE by 4 dpi.
Partial genome sequence of the 
virus was initially obtained by using 
a random priming and amplifi cation 
method as described (7). Full-length 
sequence was then determined by 
using primers designed according 
to the partial genome sequences of 
SAFV-Penang and genome sequences 
of other SAFV strains available in 
GenBank (primer sequences are 
available on request). The viral 
genome of SAFV-Penang is 8,073 nt 
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